Essential genes for tumor evaluation include EGFR, KRAS, BRAF, and PIK3CA, which play critical roles in the progression of colorectal cancer and in the selection of targeted therapies as anti-EGFR monoclonal antibodies (MoAbs) [2]. Here, EGFR is linked to neoplasm.